VIDEX Side Effects

6911350-9 | Microphthalmos, Umbilical Hernia
on Aug 02, 2010 Male patient from UNITED STATES , weighting 6.61 lb, was treated with Videx (View Usage). Patient experienced the following unwanted or unexpected effects: microphthalmos, umbilical hernia. Videx dosage: . During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), VIRAMUNE (View Viramune Review and Viramune Label ), CEFALEXIN (View Cefalexin Review and Cefalexin Label ).

6908219-2 | Aplasia Cutis Congenita, Umbilical Hernia
Patient was taking Videx (View Usage). Patient had the following side effects: aplasia cutis congenita, umbilical hernia on Jul 30, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 6.61 lb, . Videx dosage: . During the same period patient was treated with COMBIVIR (Course 1 12nov2003-21jan2004. Course 2 24jan04-14feb-2004.) (View Combivir Review and Combivir Label ), EPIVIR (View Epivir Review and Epivir Label ), KALETRA (View Kaletra Review and Kaletra Label ), VIRAMUNE (12nov03-25nov03. 26nov03-21jan04.course 2 24jan04-12feb04.course 3) (View Viramune Review and Viramune Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).

6888306-8 | Microphthalmos, Umbilical Hernia
Adverse event was reported on Jul 23, 2010 by a Male patient taking Videx (View Usage) (Dosage: ) . Location: UNITED STATES , weighting 6.61 lb, After Videx was administered, patient had the following side effects: microphthalmos, umbilical hernia. During the same period patient was treated with VIRACEPT (View Viracept Review and Viracept Label ), VIRAMUNE (View Viramune Review and Viramune Label ), CEPHALEXIN (View Cephalexin Review and Cephalexin Label ).

6888299-3 | Aplasia Cutis Congenita, Umbilical Hernia
on Jul 23, 2010 Male patient from UNITED STATES , weighting 6.61 lb, was treated with Videx (View Usage). Patient experienced the following unwanted or unexpected effects: aplasia cutis congenita, umbilical hernia. Videx dosage: . During the same period patient was treated with COMBIVIR (Course 1 12nov2003-21jan2004. Course 2 24jan04-14feb-2004.) (View Combivir Review and Combivir Label ), EPIVIR (View Epivir Review and Epivir Label ), KALETRA (View Kaletra Review and Kaletra Label ), VIRAMUNE (12nov03-25nov03. 26nov03-21jan04.course 2 24jan04-12feb04.course 3) (View Viramune Review and Viramune Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).


6816933-2 | Abdominal Pain, Anuria, Asthenia, Blood Lactic Acid Increased, Colitis, Cough, Creatinine Renal Clearance Decreased, Cytolytic Hepatitis, Dialysis
on Jun 29, 2010 Female patient from FRANCE , 48 years of age, was diagnosed with hiv infection (What is hiv infection?), hepatitis c (What is hepatitis c?) and was treated with Videx (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), anuria, asthenia, blood lactic acid increased, colitis, cough, creatinine renal clearance decreased, cytolytic hepatitis, dialysis (What is dialysis?). Videx dosage: . During the same period patient was treated with REYATAZ (View Reyataz Review and Reyataz Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ), REBETOL (View Rebetol Review and Rebetol Label ), VIRAFERONPEG (View Viraferonpeg Review and Viraferonpeg Label ), BACTRIM (View Bactrim Review and Bactrim Label ). Patient was hospitalized.

6753705-1 | Diarrhoea Haemorrhagic, Metabolic Acidosis, Respiratory Disorder
Patient was taking Videx (View Usage). After Videx was administered, patient had the following side effects: diarrhoea haemorrhagic, metabolic acidosis, respiratory disorder on May 27, 2010 from FRANCE Additional patient health information: Male patient , 50 years of age, . Videx dosage: . During the same period patient was treated with BACTRIM (1df: 2 Administrations) (View Bactrim Review and Bactrim Label ), EPIVIR (View Epivir Review and Epivir Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ), KALETRA (View Kaletra Review and Kaletra Label ). Patient was hospitalized.

6715182-6 | Cholelithiasis, Depressive Symptom, Dysphoria, Hyperbilirubinaemia, Liver Disorder, Malaise, Pancreatic Mass
Adverse event was reported on Apr 22, 2010 by a Male patient taking Videx (View Usage) (Dosage: Interrupted On 11-jun-2000,21-jul-2000 To 13-sep-2000,05-mar-2001 To 21-apr-2003) was diagnosed with hiv infection (What is hiv infection?) and. Location: JAPAN , 38 years of age, Patient experienced the following unwanted or unexpected effects: cholelithiasis, depressive symptom, dysphoria, hyperbilirubinaemia, liver disorder, malaise, pancreatic mass. During the same period patient was treated with ZERIT (7-aug-1995 To 28-oct-1996, 21-jul-2000 To 23-nov-2000, 5-mar-01 To 21-apr-03, 15-oct-03 Till Date) (View Zerit Review and Zerit Label ), REYATAZ (View Reyataz Review and Reyataz Label ), VIRACEPT (2.3g/day From 02-jan-1998 To 19-jul-1999; Initial Dates: 16-jul-1997 To 12-jan-1998) (View Viracept Review and Viracept Label ), NORVIR (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), PREZISTA (View Prezista Review and Prezista Label ), ISENTRESS (View Isentress Review and Isentress Label ), COAGULATION FACTOR VIII (Units) (View Coagulation Factor Viii Review and Coagulation Factor Viii Label ). Patient was hospitalized.

6698196-4 | Cholelithiasis, Depressive Symptom, Dysphoria, Hyperbilirubinaemia, Liver Disorder, Malaise, Pancreatic Mass
on Apr 22, 2010 Male patient from JAPAN , 28 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Videx (View Usage). Patient had the following side effects: cholelithiasis, depressive symptom, dysphoria, hyperbilirubinaemia, liver disorder, malaise, pancreatic mass. Videx dosage: Interrupted On 11-jun-2000,21-jul-2000 To 13-sep-2000,05-mar-2001 To 21-apr-2003. During the same period patient was treated with ZERIT (7-aug-1995 To 28-oct-1996, 21-jul-2000 To 23-nov-2000, 5-mar-01 To 21-apr-03, 15-oct-03 Till Date) (View Zerit Review and Zerit Label ), REYATAZ (View Reyataz Review and Reyataz Label ), VIRACEPT (2.3g/day From 02-jan-1998 To 19-jul-1999; Initial Dates: 16-jul-1997 To 12-jan-1998) (View Viracept Review and Viracept Label ), NORVIR (20-oct-1997 To 29-jan-2000, Oral) (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), PREZISTA (View Prezista Review and Prezista Label ), ISENTRESS (View Isentress Review and Isentress Label ), COAGULATION FACTOR VIII (Units) (View Coagulation Factor Viii Review and Coagulation Factor Viii Label ). Patient was hospitalized.

6695949-3 | Ascites, Blood Albumin Decreased, Hepatic Enzyme Increased, Hepatotoxicity, Pleural Effusion, Portal Vein Thrombosis, Varicose Vein, Vasodilatation
on Apr 22, 2010 Male patient from UNITED STATES , weighting 122.4 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Videx (View Usage). After Videx was administered, patient had the following side effects: ascites, blood albumin decreased, hepatic enzyme increased, hepatotoxicity, pleural effusion, portal vein thrombosis, varicose vein (What is varicose vein?), vasodilatation. Videx dosage: 250mg Once Daily Orally. During the same period patient was treated with TENOFOVIR (View Tenofovir Review and Tenofovir Label ), EFAVIRENZ (View Efavirenz Review and Efavirenz Label ), STAVUDINE (View Stavudine Review and Stavudine Label ), NELFINAVIR MESYLATE (View Nelfinavir Mesylate Review and Nelfinavir Mesylate Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6695485-4 | Fanconi Syndrome
Patient was taking Videx (View Usage). Patient experienced the following unwanted or unexpected effects: fanconi syndrome on Apr 20, 2010 from UNITED STATES Additional patient health information: Female patient , 30 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Videx dosage: Interrupted On 18mar2009, Restart On 12may2009. During the same period patient was treated with VIREAD (Interrupted On 18mar2009, Restart On 12may2009) (View Viread Review and Viread Label ), KALETRA (View Kaletra Review and Kaletra Label ).

6692228-5 | Cholangitis Chronic, Chronic Hepatitis, Portal Vein Thrombosis, Varices Oesophageal
Adverse event was reported on Apr 16, 2010 by a Male patient taking Videx (View Usage) (Dosage: Interrupted On 01aug97 Restarted On 01jul99) was diagnosed with hiv infection (What is hiv infection?), hypercholesterolaemia and. Location: FRANCE , 52 years of age, weighting 143.3 lb, Patient had the following side effects: cholangitis chronic, chronic hepatitis, portal vein thrombosis, varices oesophageal. During the same period patient was treated with VASTEN (View Vasten Review and Vasten Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), VIRAMUNE (View Viramune Review and Viramune Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ), ARIXTRA (View Arixtra Review and Arixtra Label ). Patient was hospitalized.

6686826-2 | Cholelithiasis, Depressive Symptom, Dysphoria, Hyperbilirubinaemia, Liver Disorder, Malaise, Pancreatic Mass
on Apr 12, 2010 Male patient from JAPAN , 28 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Videx (View Usage). After Videx was administered, patient had the following side effects: cholelithiasis, depressive symptom, dysphoria, hyperbilirubinaemia, liver disorder, malaise, pancreatic mass. Videx dosage: Interrupted On 11-jun-2000,21-jul-2000 To 13-sep-2000,05-mar-2001 To 21-apr-2003. During the same period patient was treated with ZERIT (7-aug-1995 To 28-oct-1996, 21-jul-2000 To 23-nov-2000, 5-mar-01 To 21-apr-03, 15-oct-03 Till Date) (View Zerit Review and Zerit Label ), REYATAZ (View Reyataz Review and Reyataz Label ), VIRACEPT (2.3g/day From 02-jan-1998 To 19-jul-1999; Initial Dates: 16-jul-1997 To 12-jan-1998) (View Viracept Review and Viracept Label ), NORVIR (20-oct-1997 To 29-jan-2000, Oral) (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), PREZISTA (View Prezista Review and Prezista Label ), ISENTRESS (View Isentress Review and Isentress Label ), COAGULATION FACTOR VIII (Units) (View Coagulation Factor Viii Review and Coagulation Factor Viii Label ). Patient was hospitalized.

6677332-X | Biopsy Liver Abnormal
on Apr 09, 2010 Female patient from UNITED STATES , weighting 114.0 lb, was diagnosed with acquired immunodeficiency syndrome and was treated with Videx (View Usage). Patient experienced the following unwanted or unexpected effects: biopsy liver abnormal. Videx dosage: Dont Remember, Was On Videx For Years. Patient was hospitalized and became disabled.

6663468-6 | Cholelithiasis, Depressive Symptom, Dysphoria, Hyperbilirubinaemia, Liver Disorder, Malaise, Pancreatic Mass
Patient was taking Videx (View Usage). Patient had the following side effects: cholelithiasis, depressive symptom, dysphoria, hyperbilirubinaemia, liver disorder, malaise, pancreatic mass on Mar 24, 2010 from JAPAN Additional patient health information: Male patient , 28 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Videx dosage: Interrupted On 11-jun-2000,21-jul-2000 To 13-sep-2000,05-mar-2001 To 21-apr-2003. During the same period patient was treated with ZERIT (7-aug-1995 To 28-oct-1996, 21-jul-2000 To 23-nov-2000, 5-mar-01 To 21-apr-03, 15-oct-03 Till Date) (View Zerit Review and Zerit Label ), REYATAZ (View Reyataz Review and Reyataz Label ), VIRACEPT (2.3g/day From 02-jan-1998 To 19-jul-1999; Initial Dates: 16-jul-1997 To 12-jan-1998) (View Viracept Review and Viracept Label ), NORVIR (20-oct-1997 To 29-jan-2000, Oral) (View Norvir Review and Norvir Label ), TRUVADA (View Truvada Review and Truvada Label ), PREZISTA (View Prezista Review and Prezista Label ), ISENTRESS (View Isentress Review and Isentress Label ), COAGULATION FACTOR VIII (Units) (View Coagulation Factor Viii Review and Coagulation Factor Viii Label ). Patient was hospitalized.

6638457-8 | Hepatosplenomegaly, Varices Oesophageal
Adverse event was reported on Mar 16, 2010 by a Female patient taking Videx (View Usage) (Dosage: Varried With Weight Bid Po) was diagnosed with hiv infection (What is hiv infection?) and. Location: UNITED STATES , weighting 160.1 lb, After Videx was administered, patient had the following side effects: hepatosplenomegaly, varices oesophageal.

6634932-0 | Oesophageal Varices Haemorrhage, Portal Hypertension
on Mar 12, 2010 Male patient from UNITED STATES , weighting 160.0 lb, was diagnosed with hiv infection (What is hiv infection?) and was treated with Videx (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal varices haemorrhage, portal hypertension. Videx dosage: 400 Mg Qd P.o.. Patient was hospitalized and became disabled.

6615814-7 | Dizziness, Palpitations, Pulmonary Hypertension
on Feb 23, 2010 Male patient from UNITED STATES , 24 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Videx (View Usage). Patient had the following side effects: dizziness (What is dizziness?), palpitations, pulmonary hypertension (What is pulmonary hypertension?). Videx dosage: 19dec94-7mar97(125mg)810d 8mar97-21jul01(300mg)1597d 22jul-14may04(400mg)1028d. During the same period patient was treated with EFAVIRENZ CAPS (24-25jul00(2d)-600mg 25sep00-02oct00(8d)) (View Efavirenz Caps Review and Efavirenz Caps Label ), ZERIT (25aug97-27feb98(187d) 28feb-03aug98(157) 4aug-9nov(98) 10nov-19jun99(222) 25dec00-20oct01(300d)) (View Zerit Review and Zerit Label ), INDINAVIR SULFATE (View Indinavir Sulfate Review and Indinavir Sulfate Label ), ZIAGEN (24jul-25jul00(2d)600mg 20oct-27oct01(8d)600mg Interrupted On 25jul00) (View Ziagen Review and Ziagen Label ), INVIRASE (19jun99-18mar00(274d) 24may00-24dec00(215d)800mg) (View Invirase Review and Invirase Label ), RITONAVIR (19jun-31oct99;400mg 01nov99-24dec00;420d 25apr05-19sep08;1244d 20sep08-cont) (View Ritonavir Review and Ritonavir Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), EPIVIR (View Epivir Review and Epivir Label ).

6596407-7 | Disease Recurrence, Liver Disorder, Oesophageal Varices Haemorrhage
Patient was taking Videx (View Usage). After Videx was administered, patient had the following side effects: disease recurrence, liver disorder, oesophageal varices haemorrhage on Feb 22, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 136.2 lb, was diagnosed with acquired immunodeficiency syndrome and. Videx dosage: 250 Mg Qd Oral. During the same period patient was treated with VIDEX EC (400 Mg Qd Oral) (View Videx Ec Review and Videx Ec Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), COMBIVIR (View Combivir Review and Combivir Label ), REYATAZ (View Reyataz Review and Reyataz Label ), NORVIR (View Norvir Review and Norvir Label ), VIREAD (View Viread Review and Viread Label ), LEXIVA (View Lexiva Review and Lexiva Label ), EPZICOM (View Epzicom Review and Epzicom Label ). Patient was hospitalized and became disabled.

6547054-4 | Dry Mouth, Weight Decreased, Xerophthalmia
Adverse event was reported on Jan 19, 2010 by a Male patient taking Videx (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?) and. Location: FRANCE , 59 years of age, Patient experienced the following unwanted or unexpected effects: dry mouth, weight decreased, xerophthalmia. During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), VIREAD (Virea,1tab) (View Viread Review and Viread Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), PLAVIX (View Plavix Review and Plavix Label ).

6426268-8 | Eyelid Ptosis, Facial Palsy, Lipodystrophy Acquired
on Oct 29, 2009 Male patient from NEW ZEALAND , 47 years of age, was diagnosed with hiv infection (What is hiv infection?), hyperlipidaemia and was treated with Videx (View Usage). Patient had the following side effects: eyelid ptosis, facial palsy, lipodystrophy acquired. Videx dosage: . During the same period patient was treated with ZERIT (View Zerit Review and Zerit Label ), VIRACEPT (View Viracept Review and Viracept Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ).

6422060-9 | Eyelid Ptosis, Lipodystrophy Acquired
on Oct 26, 2009 Male patient from NEW ZEALAND , 47 years of age, was diagnosed with hiv infection (What is hiv infection?), hyperlipidaemia and was treated with Videx (View Usage). After Videx was administered, patient had the following side effects: eyelid ptosis, lipodystrophy acquired. Videx dosage: . During the same period patient was treated with ZERIT (View Zerit Review and Zerit Label ), VIRACEPT (View Viracept Review and Viracept Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ).

6337714-2 | Cerebrovascular Accident
Patient was taking Videx (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident on Aug 28, 2009 from UNITED KINGDOM Additional patient health information: Male patient , 76 years of age, . Videx dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PERINDOPRIL (View Perindopril Review and Perindopril Label ). Patient was hospitalized.

6313716-7 | Lactic Acidosis, Normal Newborn
Adverse event was reported on Jul 27, 1999 by a Female patient taking Videx (View Usage) (Dosage: ) was diagnosed with hiv infection (What is hiv infection?), anxiety (What is anxiety?) and. Location: UNITED STATES , 34 years of age, Patient had the following side effects: lactic acidosis, normal newborn. During the same period patient was treated with ZERIT (View Zerit Review and Zerit Label ), LAMIVUDINE + ZIDOVUDINE (View Lamivudine + Zidovudine Review and Lamivudine + Zidovudine Label ), SAQUINAVIR (View Saquinavir Review and Saquinavir Label ), PAXIL (View Paxil Review and Paxil Label ). Patient was hospitalized.

6313584-3 | Hepatic Cirrhosis, Peritoneal Fibrosis
on Aug 13, 2009 Male patient from UNITED KINGDOM , 51 years of age, weighting 132.3 lb, was treated with Videx (View Usage). After Videx was administered, patient had the following side effects: hepatic cirrhosis, peritoneal fibrosis. Videx dosage: .

6249706-2 | Diabetes Mellitus, Haematemesis, Hepatic Cirrhosis, Hepatic Steatosis, Lipodystrophy Acquired, Portal Hypertension, Varices Oesophageal
on Jun 24, 2009 Male patient from FRANCE , 34 years of age, was treated with Videx (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, haematemesis, hepatic cirrhosis, hepatic steatosis, lipodystrophy acquired, portal hypertension, varices oesophageal. Videx dosage: 1997 To 1998 Then From 2000 To 2002. During the same period patient was treated with SUSTIVA (1998 To 2000 Then From 04-apr-2002) (View Sustiva Review and Sustiva Label ), ZERIT (View Zerit Review and Zerit Label ), REYATAZ (From 17-may-2004) (View Reyataz Review and Reyataz Label ), RETROVIR (View Retrovir Review and Retrovir Label ), EPIVIR (View Epivir Review and Epivir Label ), VIRACEPT (View Viracept Review and Viracept Label ), KALETRA (From 2002 To 2004) (View Kaletra Review and Kaletra Label ), ZIAGEN (From 04-apr-2002 2004) (View Ziagen Review and Ziagen Label ). Patient was hospitalized.

6228147-8 | Anaemia, Asthenia, Dyspnoea
Patient was taking Videx (View Usage). Patient had the following side effects: anaemia, asthenia, dyspnoea on Jun 09, 2009 from FRANCE Additional patient health information: Female patient , 33 years of age, . Videx dosage: . During the same period patient was treated with COMBIVIR (1df=150mg/300mg) (View Combivir Review and Combivir Label ). Patient was hospitalized.

6209594-7 | Ascites
Adverse event was reported on May 28, 2009 by a Male patient taking Videx (View Usage) (Dosage: Videx 250 Mg Gastro-resistant Capsules, 30 Capsules) was diagnosed with hiv infection (What is hiv infection?) and. Location: SPAIN , 44 years of age, After Videx was administered, patient had the following side effects: ascites. Patient was hospitalized.

6190421-1 | Eyelid Ptosis, Facial Wasting
on May 12, 2009 Male patient from UNITED STATES , 57 years of age, was diagnosed with hiv infection (What is hiv infection?) and was treated with Videx (View Usage). Patient experienced the following unwanted or unexpected effects: eyelid ptosis, facial wasting. Videx dosage: . During the same period patient was treated with LEXIVA (View Lexiva Review and Lexiva Label ), EPIVIR (View Epivir Review and Epivir Label ).

6190416-8 | Eyelid Ptosis, Facial Wasting
on May 12, 2009 Male patient from UNITED STATES , 53 years of age, was treated with Videx (View Usage). Patient had the following side effects: eyelid ptosis, facial wasting. Videx dosage: . During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6185515-0 | Eyelid Ptosis, Facial Wasting
Patient was taking Videx (View Usage). After Videx was administered, patient had the following side effects: eyelid ptosis, facial wasting on May 04, 2009 from UNITED STATES Additional patient health information: Male patient , 57 years of age, . Videx dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), LEXIVA (View Lexiva Review and Lexiva Label ).

6183043-X | Eyelid Ptosis, Facial Wasting
Adverse event was reported on May 04, 2009 by a Male patient taking Videx (View Usage) (Dosage: ) . Location: UNITED STATES , 53 years of age, Patient experienced the following unwanted or unexpected effects: eyelid ptosis, facial wasting. During the same period patient was treated with VIREAD (View Viread Review and Viread Label ), ZIAGEN (View Ziagen Review and Ziagen Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6182875-1 | Eyelid Ptosis, Facial Wasting
on May 04, 2009 Male patient from UNITED STATES , 57 years of age, was treated with Videx (View Usage). Patient had the following side effects: eyelid ptosis, facial wasting. Videx dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), LEXIVA (View Lexiva Review and Lexiva Label ).

6155749-X | Atrial Septal Defect, Tricuspid Valve Incompetence, Ventricular Septal Defect
on Apr 09, 2009 Female patient from UNITED STATES , weighting 6.61 lb, was treated with Videx (View Usage). After Videx was administered, patient had the following side effects: atrial septal defect, tricuspid valve incompetence, ventricular septal defect. Videx dosage: . During the same period patient was treated with REYATAZ (View Reyataz Review and Reyataz Label ), EPIVIR (View Epivir Review and Epivir Label ), COMBIVIR (Tablet;1df=150/300mg.) (View Combivir Review and Combivir Label ), RETROVIR (View Retrovir Review and Retrovir Label ).

6145673-0 | Atrial Septal Defect, Tricuspid Valve Incompetence, Ventricular Septal Defect
Patient was taking Videx (View Usage). Patient experienced the following unwanted or unexpected effects: atrial septal defect, tricuspid valve incompetence, ventricular septal defect on Apr 01, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 6.61 lb, . Videx dosage: . During the same period patient was treated with REYATAZ (View Reyataz Review and Reyataz Label ), EPIVIR (View Epivir Review and Epivir Label ), COMBIVIR (Tablet;1df=150/300mg.) (View Combivir Review and Combivir Label ), RETROVIR (View Retrovir Review and Retrovir Label ).

6137210-1 | Blood Cholesterol Increased, Lipodystrophy Acquired, Myocardial Infarction
Adverse event was reported on Mar 23, 2009 by a Female patient taking Videx (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 45 years of age, Patient had the following side effects: blood cholesterol increased, lipodystrophy acquired, myocardial infarction. During the same period patient was treated with STAVUDINE (View Stavudine Review and Stavudine Label ), LOPINAVIR AND RITONAVIR (View Lopinavir And Ritonavir Review and Lopinavir And Ritonavir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ).

6111860-0 | Atrial Septal Defect, Tricuspid Valve Incompetence, Ventricular Septal Defect
on Mar 08, 2009 Female patient from UNITED STATES , weighting 6.61 lb, was treated with Videx (View Usage). After Videx was administered, patient had the following side effects: atrial septal defect, tricuspid valve incompetence, ventricular septal defect. Videx dosage: . During the same period patient was treated with REYATAZ (View Reyataz Review and Reyataz Label ), EPIVIR (View Epivir Review and Epivir Label ), COMBIVIR (Tablet;1df=150/300mg.) (View Combivir Review and Combivir Label ), RETROVIR (View Retrovir Review and Retrovir Label ).

6105910-5 | Blood Lactic Acid Increased, Blood Phosphorus Decreased, Mitochondrial Cytopathy, Overdose, Renal Tubular Disorder
on Mar 04, 2009 Male patient from FRANCE , 41 years of age, was treated with Videx (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactic acid increased, blood phosphorus decreased, mitochondrial cytopathy, overdose, renal tubular disorder. Videx dosage: . During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), VIREAD (1 Df= 1 Tablet) (View Viread Review and Viread Label ), KALETRA (1 Df= 4 Tablets) (View Kaletra Review and Kaletra Label ), DEPAKENE (View Depakene Review and Depakene Label ), TEGRETOL (Lp One Unit) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

6104532-X | Atrial Septal Defect, Tricuspid Valve Incompetence, Ventricular Septal Defect
Patient was taking Videx (View Usage). Patient had the following side effects: atrial septal defect, tricuspid valve incompetence, ventricular septal defect on Mar 02, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 6.61 lb, . Videx dosage: . During the same period patient was treated with REYATAZ (View Reyataz Review and Reyataz Label ), EPIVIR (View Epivir Review and Epivir Label ), COMBIVIR (Tablet;1df=150/300mg.) (View Combivir Review and Combivir Label ), RETROVIR (View Retrovir Review and Retrovir Label ).

6101688-X | Diabetes Mellitus, Haematemesis, Hepatic Cirrhosis, Hepatic Steatosis, Lipodystrophy Acquired, Varices Oesophageal
Adverse event was reported on Mar 02, 2009 by a Male patient taking Videx (View Usage) (Dosage: 1997 To 1998 Then From 2000 To 2002) . Location: FRANCE , 34 years of age, After Videx was administered, patient had the following side effects: diabetes mellitus, haematemesis, hepatic cirrhosis, hepatic steatosis, lipodystrophy acquired, varices oesophageal. During the same period patient was treated with SUSTIVA (1998 To 2000 Then From 04-apr-2002) (View Sustiva Review and Sustiva Label ), ZERIT (View Zerit Review and Zerit Label ), REYATAZ (From 17-may-2004) (View Reyataz Review and Reyataz Label ), RETROVIR (View Retrovir Review and Retrovir Label ), EPIVIR (View Epivir Review and Epivir Label ), VIRACEPT (View Viracept Review and Viracept Label ), KALETRA (From 2002 To 2004) (View Kaletra Review and Kaletra Label ), ZIAGEN (From 04-apr-2002 2004) (View Ziagen Review and Ziagen Label ). Patient was hospitalized.

6094940-8 | Diabetes Mellitus, Haematemesis, Hepatic Cirrhosis, Hepatic Steatosis, Lipodystrophy Acquired, Varices Oesophageal
on Feb 26, 2009 Male patient from FRANCE , 34 years of age, was treated with Videx (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, haematemesis, hepatic cirrhosis, hepatic steatosis, lipodystrophy acquired, varices oesophageal. Videx dosage: 1997 To 1998 Then From 2000 To 2002. During the same period patient was treated with SUSTIVA (1998 To 2000 Then From 04-apr-2002) (View Sustiva Review and Sustiva Label ), ZERIT (View Zerit Review and Zerit Label ), REYATAZ (From 17-may-2004) (View Reyataz Review and Reyataz Label ), RETROVIR (View Retrovir Review and Retrovir Label ), EPIVIR (View Epivir Review and Epivir Label ), VIRACEPT (View Viracept Review and Viracept Label ), KALETRA (From 2002 To 2004) (View Kaletra Review and Kaletra Label ), ZIAGEN (From 04-apr-2002 2004) (View Ziagen Review and Ziagen Label ). Patient was hospitalized.

6085503-9 | Diabetes Mellitus, Haematemesis, Hepatic Cirrhosis, Hepatic Steatosis, Lipodystrophy Acquired, Varices Oesophageal
on Feb 17, 2009 Male patient from FRANCE , 34 years of age, was treated with Videx (View Usage). Patient had the following side effects: diabetes mellitus, haematemesis, hepatic cirrhosis, hepatic steatosis, lipodystrophy acquired, varices oesophageal. Videx dosage: 1997 To 1998 Then From 2000 To 2002. During the same period patient was treated with SUSTIVA (1998 To 2000 Then From 04-apr-2002) (View Sustiva Review and Sustiva Label ), ZERIT (View Zerit Review and Zerit Label ), REYATAZ (From 17-may-2004) (View Reyataz Review and Reyataz Label ), RETROVIR (View Retrovir Review and Retrovir Label ), EPIVIR (View Epivir Review and Epivir Label ), VIRACEPT (View Viracept Review and Viracept Label ), KALETRA (From 2002 To 2004) (View Kaletra Review and Kaletra Label ), ZIAGEN (From 04-apr-2002 2004) (View Ziagen Review and Ziagen Label ). Patient was hospitalized.

6052731-8 | Portal Hypertension
Patient was taking Videx (View Usage). After Videx was administered, patient had the following side effects: portal hypertension on Jan 21, 2009 from UNITED STATES Additional patient health information: Male patient , child 12 years of age, was diagnosed with hiv infection (What is hiv infection?) and. Videx dosage: . During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), ZIAGEN (View Ziagen Review and Ziagen Label ).

6048251-7 | Blood Lactic Acid Increased, Blood Phosphorus Decreased, Mitochondrial Cytopathy, Overdose, Renal Tubular Disorder
Adverse event was reported on Jan 19, 2009 by a Male patient taking Videx (View Usage) (Dosage: ) . Location: FRANCE , 41 years of age, Patient experienced the following unwanted or unexpected effects: blood lactic acid increased, blood phosphorus decreased, mitochondrial cytopathy, overdose, renal tubular disorder. During the same period patient was treated with SUSTIVA (View Sustiva Review and Sustiva Label ), VIREAD (1 Df= 1 Tablet) (View Viread Review and Viread Label ), KALETRA (1 Df= 4 Tablets) (View Kaletra Review and Kaletra Label ), DEPAKENE (View Depakene Review and Depakene Label ), TEGRETOL (Lp One Unit) (View Tegretol Review and Tegretol Label ). Patient was hospitalized.

6035800-8 | Vomiting
on Jan 09, 2009 Male patient from PORTUGAL , 33 years of age, weighting 152.1 lb, was treated with Videx (View Usage). Patient had the following side effects: vomiting. Videx dosage: 1 Df= Didanosine 250, 1 Tablet/day. During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), PEGINTERFERON ALFA 2A (View Peginterferon Alfa-2a Review and Peginterferon Alfa-2a Label ), VIREAD (View Viread Review and Viread Label ), VIRAMUNE (View Viramune Review and Viramune Label ).

6006589-3 | Pregnancy, Stillbirth
on Nov 19, 2008 Female patient from UNITED STATES , weighting 2.20 lb, was treated with Videx (View Usage). After Videx was administered, patient had the following side effects: pregnancy (What is pregnancy?), stillbirth. Videx dosage: . During the same period patient was treated with RETROVIR (View Retrovir Review and Retrovir Label ), KALETRA (1 Dosage Form=800mg/200mg) (View Kaletra Review and Kaletra Label ), EPIVIR (View Epivir Review and Epivir Label ).

5988448-5 | Coronary Artery Occlusion, Myocardial Infarction, Pneumonia
Patient was taking Videx (View Usage). Patient experienced the following unwanted or unexpected effects: coronary artery occlusion, myocardial infarction, pneumonia (What is pneumonia?) on Dec 08, 2008 from POLAND Additional patient health information: Male patient , 34 years of age, weighting 141.1 lb, was diagnosed with hiv infection (What is hiv infection?) and. Videx dosage: . During the same period patient was treated with REYATAZ (Reyataz 150, 1x2tabl From 30 November) (View Reyataz Review and Reyataz Label ), ZIAGEN (Tab,2x1tabl) (View Ziagen Review and Ziagen Label ), NORVIR (View Norvir Review and Norvir Label ). Patient was hospitalized.

5977836-9 | Bladder Spasm, Urinary Tract Disorder
Adverse event was reported on Oct 19, 2007 by a Female patient taking Videx (View Usage) (Dosage: ) . Location: UNITED STATES , child 9 years of age, Patient had the following side effects: bladder spasm, urinary tract disorder. During the same period patient was treated with NORVIR (View Norvir Review and Norvir Label ), RETROVIR (View Retrovir Review and Retrovir Label ), LEXIVA (View Lexiva Review and Lexiva Label ).

5933715-4 | Cytolytic Hepatitis, Renal Failure
on Oct 24, 2008 Male patient from UNITED KINGDOM , 65 years of age, was diagnosed with hepatitis b virus test and was treated with Videx (View Usage). After Videx was administered, patient had the following side effects: cytolytic hepatitis, renal failure. Videx dosage: . During the same period patient was treated with TRUVADA (View Truvada Review and Truvada Label ), HEPSERA (10mg 1in1d Frm May04-sep07 5mg 1in2d Frm Sep07-mar08(6months) Mar-08 To Jul-08) (View Hepsera Review and Hepsera Label ), ZEFFIX (100mg 1in1d Frm Apr06-sep07 (1yr) 50mg 1in1d Frm Sep07-mar08(6months)) (View Zeffix Review and Zeffix Label ), SUSTIVA (View Sustiva Review and Sustiva Label ), REYATAZ (View Reyataz Review and Reyataz Label ), NORVIR (View Norvir Review and Norvir Label ), NORSET (View Norset Review and Norset Label ), CRESTOR (View Crestor Review and Crestor Label ). Patient was hospitalized.

5875073-X | Abdominal Distension, Abdominal Pain, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Lactic Acid Increased, Blood Ph Abnormal, Candidiasis, Constipation, Escherichia Infection
on Sep 05, 2008 Female patient from UNITED KINGDOM , 39 years of age, weighting 99.21 lb, was diagnosed with hiv infection (What is hiv infection?), prophylaxis and was treated with Videx (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain (What is abdominal pain?), blood creatine phosphokinase increased, blood creatinine increased, blood lactic acid increased, blood ph abnormal, candidiasis, constipation (What is constipation?), escherichia infection. Videx dosage: . During the same period patient was treated with EPIVIR (View Epivir Review and Epivir Label ), NEVIRAPINE (View Nevirapine Review and Nevirapine Label ), INDINIVIR SULFATE (View Indinivir Sulfate Review and Indinivir Sulfate Label ), SEPTRIN (View Septrin Review and Septrin Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ). Patient was hospitalized.

5873517-0 | Anorexia, Ergot Poisoning, Malaise, Myalgia, Nausea, Necrosis, Paraesthesia, Pulse Absent, Vertigo
Patient was taking Videx (View Usage). Patient had the following side effects: anorexia, ergot poisoning, malaise, myalgia, nausea (What is nausea?), necrosis, paraesthesia, pulse absent, vertigo on Sep 03, 2008 from SWITZERLAND Additional patient health information: Female patient , 40 years of age, was diagnosed with acquired immunodeficiency syndrome and. Videx dosage: . During the same period patient was treated with ZERIT (View Zerit Review and Zerit Label ), NORVIR (View Norvir Review and Norvir Label ), BELLERGAL (2 Dosageform = 2 Tabs) (View Bellergal Review and Bellergal Label ). Patient was hospitalized.